120 related articles for article (PubMed ID: 17009630)
1. Studies on leptin and leptin receptor gene expression in myometrium and uterine myomas of gnRH analogue-treated women.
Markowska A; Rucinski M; Drews K; Malendowicz LK
Eur J Gynaecol Oncol; 2006; 27(4):379-84. PubMed ID: 17009630
[TBL] [Abstract][Full Text] [Related]
2. Further studies on leptin and leptin receptor expression in myometrium and uterine myomas.
Markowska A; Rucinski M; Drews K; Malendowicz LK
Eur J Gynaecol Oncol; 2005; 26(5):517-25. PubMed ID: 16285570
[TBL] [Abstract][Full Text] [Related]
3. Leptin and leptin receptor expression in the myometrium and uterine myomas: Is leptin involved in tumor development?
Markowska A; Belloni AS; Rucinski M; Parenti AR; Nardelli GB; Drews K; Nussdorfer GG; Malendowicz LK
Int J Oncol; 2005 Dec; 27(6):1505-9. PubMed ID: 16273205
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the inhibitory effect of gonadotropin releasing hormone (GnRH) agonist, selective estrogen receptor modulator (SERM), antiprogesterone on myoma cell proliferation in vitro.
Chung YJ; Chae B; Kwak SH; Song JY; Lee AW; Jo HH; Lew YO; Kim JH; Kim MR
Int J Med Sci; 2014; 11(3):276-81. PubMed ID: 24516352
[TBL] [Abstract][Full Text] [Related]
5. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy.
Luo X; Ding L; Xu J; Williams RS; Chegini N
Endocrinology; 2005 Mar; 146(3):1074-96. PubMed ID: 15604208
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of selected pro-inflammatory factors in uterine myomas and myometrium in women of various ages.
Plewka A; Madej P; Plewka D; Kowalczyk A; Miskiewicz A; Wittek P; Leks T; Bilski R
Folia Histochem Cytobiol; 2013; 51(1):73-83. PubMed ID: 23690221
[TBL] [Abstract][Full Text] [Related]
7. Receptors of hypothalamic-pituitary-ovarian-axis hormone in uterine myomas.
Plewka D; Marczyński J; Morek M; Bogunia E; Plewka A
Biomed Res Int; 2014; 2014():521313. PubMed ID: 25050358
[TBL] [Abstract][Full Text] [Related]
8. Human myometrium and leiomyomas express gonadotropin-releasing hormone 2 and gonadotropin-releasing hormone 2 receptor.
Parker JD; Malik M; Catherino WH
Fertil Steril; 2007 Jul; 88(1):39-46. PubMed ID: 17296196
[TBL] [Abstract][Full Text] [Related]
9. The TRAF2 and TRAF6 expression in myomas and myometrium of women in reproduction and perimenopausal age.
Plewka A; Madej P; Plewka D; Nowaczyk G; Morek M; Bogunia E; Ciupińska-Kajor M; Sieroń-Stołtny K
Folia Histochem Cytobiol; 2010 Sep; 48(3):407-16. PubMed ID: 21071347
[TBL] [Abstract][Full Text] [Related]
10. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs.
van de Ven J; Sprong M; Donker GH; Thijssen JH; Mak-Kregar S; Blankenstein MA
Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():61-8. PubMed ID: 12227888
[TBL] [Abstract][Full Text] [Related]
11. Expression of exon 5 deleted estrogen receptor variant messenger RNA in human uterine myometrium and leiomyoma.
Mito K; Tamura T; Hosokawa K; Kondo T; Yamamoto T; Honjo H
J Steroid Biochem Mol Biol; 1998 Oct; 67(1):9-16. PubMed ID: 9780024
[TBL] [Abstract][Full Text] [Related]
12. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
Vollenhoven BJ; Pearce P; Herington AC; Healy DL
Clin Endocrinol (Oxf); 1994 Apr; 40(4):537-44. PubMed ID: 8187322
[TBL] [Abstract][Full Text] [Related]
13. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
14. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
Chegini N; Verala J; Luo X; Xu J; Williams RS
J Soc Gynecol Investig; 2003 Apr; 10(3):161-71. PubMed ID: 12699880
[TBL] [Abstract][Full Text] [Related]
16. Versican Proteolysis by ADAMTS Proteases and Its Influence on Sex Steroid Receptor Expression in Uterine Leiomyoma.
Gueye NA; Mead TJ; Koch CD; Biscotti CV; Falcone T; Apte SS
J Clin Endocrinol Metab; 2017 May; 102(5):1631-1641. PubMed ID: 28323982
[TBL] [Abstract][Full Text] [Related]
17. Oxytocin receptor and its messenger ribonucleic acid in human leiomyoma and myometrium.
Lee KH; Khan-Dawood FS; Dawood MY
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):620-7. PubMed ID: 9757961
[TBL] [Abstract][Full Text] [Related]
18. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
Luo X; Ding L; Chegini N
Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
[TBL] [Abstract][Full Text] [Related]
19. Gene and protein expression of progesterone receptor isoforms A and B, p53 and p21 in myometrium and uterine leiomyoma.
Lora V; Grings AO; Capp E; von Eye Corleta H; Brum IS
Arch Gynecol Obstet; 2012 Jul; 286(1):119-24. PubMed ID: 22350293
[TBL] [Abstract][Full Text] [Related]
20. Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity.
Rackow BW; Taylor HS
Fertil Steril; 2010 Apr; 93(6):2027-34. PubMed ID: 18555231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
